A conceptual agentic AI architecture for MASLD-associated significant fibrosis in primary care
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent yet often underdiagnosed or undertreated in primary care due to asymptomatic early disease, uneven uptake of non‑invasive tests, limited elastography access, competing clinic... ...
